-
Product Insights
NewCardiac Ablation Devices Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Cardiac Ablation Devices Pipeline Market Report Overview Cardiac ablation devices use radiofrequency energy to destroy cardiac tissues which propagate incorrect electrical signals to cause an abnormal heart rhythm. The cardiac ablation devices pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated...
-
Company Insights
NewWorldline – Competitor Profile
Worldline Group is one of the world’s leading payment and transactional service providers, offering end-to-end solutions covering the entire payment value chain. It has omnichannel solutions for merchants, banks, acquirers, payment services providers (PSPs), businesses, and governments. Worldline operates its services in 170 countries, supporting payments in 140 currencies. Worldline operates through three segments—Merchant Services, Financial Services, and Mobility & e-Transactional Services—offering acquiring and processing, card issuing processing, clearing and settlement, open banking, and mobile banking services. Previously, it had...
-
Product Insights
NewClinical Trials Scorecard for Investigations in 2023
This report provides an overview of global clinical trials with a start date between January 1, 2023, and December 31, 2023.
-
Sector Analysis
NewUnited Arab Emirates (UAE) Defense Market Size, Trends, Budget Allocation, Regulations, Acquisitions, Competitive Landscape and Forecast to 2029
United Arab Emirates (UAE) Defense Market Report Overview The United Arab Emirates (UAE) defense budget is estimated to be valued at $25 billion in 2024, due to the need to finance procurements. The country’s defense budget will grow at a CAGR of more than 4% during 2025-2029, owing to the need to modernize the UAE Defense and Security Forces, with specific emphasis on counter-insurgency measures. United Arab Emirates (UAE) Defense Market Outlook, 2024-2029 ($ Billion) Buy the Full Report for...
-
Product Insights
NewLikelihood of Approval Analysis for Amyotrophic Lateral Sclerosis
Overview How likely is it that the drugs in Amyotrophic Lateral Sclerosis will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Amyotrophic Lateral Sclerosis Overview Amyotrophic lateral sclerosis (ALS), also known as...
-
Company Insights
NewGlobal Payments – Competitor Profile
Global Payments is a global merchant acquiring and payment processing company that connects merchants directly to all major and local card schemes and alternative payment methods. The company enables merchants to accept payments through both online and offline channels. Global Payments offers services to four million merchant locations globally, enabling them to accept payments via 150 payment methods (including digital wallets, card payments, and local and alternative payment methods). In addition to ecommerce payment acceptance for individual merchants, Global Payments...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ELX-02 in Cystic Fibrosis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ELX-02 in Cystic Fibrosis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ELX-02 in Cystic Fibrosis Drug Details: ELX-02 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Pelabresib in Essential Thrombocythemia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Pelabresib in Essential Thrombocythemia report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Pelabresib in Essential Thrombocythemia Drug Details: Pelabresib (CPI-0610) is under development...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Ondansetron Hydrochloride in Chemotherapy Induced Nausea and Vomiting
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Ondansetron Hydrochloride in Chemotherapy Induced Nausea and Vomiting report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Ondansetron Hydrochloride in Chemotherapy Induced Nausea and Vomiting...